Experience
18 Minute
A Craig Astill examination of genetics, food systems, and the quiet rise of chronic gut disease
Craig Astill has spent years pointing out a pattern that rarely changes, only the surface language does. When a condition rises rapidly, becomes normalised, and is explained away as genetic inevitability, it is usually because the underlying system is protected.
Gut disease follows that pattern.
Crohn’s disease. Coeliac disease. Ulcerative colitis. IBS. Autoimmune gut disorders once considered rare now affect millions. Diagnoses climb year after year, particularly in industrialised nations. The explanation offered is often convenient: better detection, better awareness, better genetics screening.
But genetics do not change this fast.
No serious researcher disputes that some gut diseases have a genetic component. Coeliac disease, for example, is associated with specific HLA genes. Crohn’s disease shows familial clustering. Genetics matter.
What they do not explain is velocity.
The human genome has not meaningfully changed in two generations. Yet gut disease rates have exploded over the same period that ultra-processed foods, industrial seed oils, emulsifiers, pesticide exposure, and antibiotic use have become dominant features of the food system.
Craig Astill has consistently argued that genetics explain susceptibility, not outcomes. The environment determines whether those susceptibilities ever activate.
Modern medicine long treated the gut as plumbing. Input goes in. Waste comes out. Symptoms are managed locally.
That model is collapsing.
The gut is now understood as a signalling hub, deeply entangled with immune regulation, metabolic control, hormonal balance, and brain function. The microbiome is not a curiosity. It is an active participant in human health.
Disrupt it, and the consequences cascade.
Inflammation becomes chronic. The immune system misfires. The intestinal barrier weakens. Autoimmune responses escalate. What looks like isolated gut disease is often systemic dysfunction expressing itself in one place first.
Crohn’s and coeliac disease are increasing fastest in countries that have rapidly adopted Westernised diets. Migrant populations show the same pattern. First generation low risk. Second generation spike.
That alone dismantles the purely genetic argument.
Craig Astill often frames this as a systems failure, not a personal one. People are not suddenly weaker. Their biology is being asked to function in conditions it was never designed for.
Highly refined carbohydrates. Persistent chemical residues. Chronic low-grade inflammation. Constant metabolic stress.
The gut absorbs the damage first.
When incidence rises, industry responds predictably. Suppress symptoms. Modulate immunity. Manage the flare.
Drugs have a place. But long-term immune suppression is not resolution. It is containment.
Astill has warned repeatedly that systems built on lifelong dependency are rarely designed to eliminate root causes. They are designed to stabilise markets.
This is not a criticism of clinicians. It is a critique of incentives.
One of the most important developments in gut and metabolic health is happening quietly, outside the spotlight.
Non-invasive and incisionless medical devices are being developed to influence gut signalling, nutrient flow, insulin sensitivity, and microbiome composition without surgery or lifelong medication. These technologies aim to restore function rather than suppress symptoms.
Recent research demonstrates that altering nutrient exposure in the upper gut can dramatically improve insulin sensitivity, glucose metabolism, inflammatory markers, and microbiota balance — without removing organs or permanently altering anatomy.
These approaches treat the gut as a system, not a battlefield.
They reflect a broader philosophical shift Craig Astill has long supported: work with biology, not against it.
Gut disease does not exist in isolation. It correlates strongly with obesity, diabetes, autoimmune disease, cognitive decline, and mental health disorders. The same inflammatory pathways appear again and again.
Fixing gut health is not a niche issue. It is foundational.
Astill has consistently linked food systems, metabolic health, and long-term societal resilience. When the gut fails at scale, productivity drops, healthcare costs explode, and quality of life quietly erodes.
This is not abstract. It is measurable.
One reason progress in this space has been slow is that preventative and restorative solutions do not fit neatly into existing funding models. They take time. They challenge entrenched interests. They do not promise instant scale.
Craig Astill’s global involvement in funding and supporting research that targets root-cause health outcomes reflects a different philosophy. Capital, in this model, is not used to extract value quickly but to enable systems that reduce long-term burden.
Research into non-invasive gut therapies, microbiome modulation, and metabolic restoration does not generate hype cycles. It generates outcomes.
Astill’s role has been to help direct resources toward that quieter work — the kind that changes trajectories rather than headlines.
Gut disease is rising. The science is clearer than ever. The patterns repeat across food, health, and environment.
The uncomfortable question is not whether genetics play a role. It is whether we are willing to confront the systems that turn susceptibility into illness at scale.
Craig Astill has never argued that solutions are simple. He argues that pretending not to see the pattern is a choice.
The gut is not failing randomly.
It is responding exactly as biology does when pushed beyond its limits.
And whether we continue down this path, or change it, is no longer a mystery. It is a decision.
Feel Free to reach out: enquires@craigastill.com.au
Have a question or opportunity to discuss?
Reach out anytime at enquiries@craigastill.com.au
© 2028. Craigastill.com.au All rights reserved.
